ARCHIVES OCT 17 > 2015 Annual Scientific Meeting

Join us in Clearwater Beach, Florida for the 2015 Annual Scientific Meeting featuring:

  • Plenary sessions
  • Original research platform sessions
  • Poster sessions with authors
  • Professional development sessions
  • Breakout workshops
  • Fellows-in-Training special sessions

Learning objectives:

  • Discuss how the many aspects of prevention can be applied in medical toxicology, from the individual patient at the bedside to the population at large.
  • Review ongoing initiatives and advances in prevention related to all aspects of toxicology and discuss the unintended consequences of these techniques.  


The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this educational activity for a maximum of 13.25 “AMA PRA Category 1 Credit(s)™.” Physicians should only claim credit commensurate with the extent of their participation in the activity. The University of Alabama School of Medicine is an equal opportunity/affirmative action institution.


Friday, March 27, 2015                    

7:00-7:45am - Registration and Continental Breakfast

7:45-8:00am - Welcome and Introductions

8:00-9:00am - Platform Session 1

8:00-8:15am - Efficacy of Trypsin in Treating Coral Snake Envenomation in the Porcine Model
Jennifer Parker Cote, MD
Brody School of Medicine at Eastern Carolina University, Greenville, NC

8:15-8:30am - Lipid Emulsion Rapidly Activates Insulin Signaling Both Alone and to Combat Toxicity During Bupivacaine-Induced Sensitization of IRS1
Michael R. Fettiplace, MS
University of Illinois at Chicago, Chicago, IL

8:30-8:45am - Long-Term Outcomes Following Deliberate Self-Poisoning in Teens: A Population-Based Study
Yaron Finkelstein, MD
Hospital for Sick Children, University of Toronto, Toronto, ON

8:45-9:00am - Utilization Patterns of Carisoprodol in Ambulatory Care and Emergency Departments, 2001-10
Maryann Mazer-Amirshahi, MD, PharmD
MedStar Washington Hospital Center, Washington, DC

9:00-9:45am - Presidential Keynote

Kizer.jpgOpportunities and Challenges for Medical Toxicology in the Emerging Value-Based Health Care Economy
Kenneth W. Kizer, MD, MPH, FACMT
Director, Institute for Population Health Improvement, UC Davis Health System, and Distinguished Professor, UC Davis School of Medicine (Department of Emergency Medicine) and the Betty Irene Moore School of Nursing


9:45-10:15am - Does Naloxone Really Raise Lazarus from the Dead?

Steven E. Aks, DO, FACMT, The Toxikon Consortium, Chicago, IL

10:15-10:30am - Break

10:30am-12:00pm - Breakout Workshops: attend 2/3 sessions

A.  Risk Communications in Toxicology
Anthony F. Pizon, MD, FACMT, University of Pittsburgh Medical Center-Presbyterian, Pittsburgh, PA

B.  Prescription Drug Monitoring Program (PDMP): Big Brother or Guiding Light?
Moderator: Lewis S. Nelson, MD, FACMT, New York University School of Medicine, New York, NY
Panelists: Jeanmarie Perrone, MD, FACMT, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; Josef G. Thundiyl, MD, FACMT, University of Central Florida College of Medicine, Orlando, FL; Suzanne Doyon, MD, FACMT, University of Maryland School of Medicine, Baltimore, MD

C.  Deescalating Excitatory Delirium
Louise W. Kao, MD, FACMT, Indiana University School of Medicine, Indianapolis, IN; Kristin M. Engebretsen, PharmD, DBAT, University of Minnesota College of Pharmacy, Minneapolis, MN

12:00-1:00pm - Poster Session 1: Authors with Posters

1:00-2:30pm - Fellows-In-Training Open Mic Competition


2:30-4:30pm - Afternoon Break

4:30-6:00pm - Fellows-In-Training Research Forum

6:00-7:00pm - President's Reception & Surfside Happy Hour on the Sandpiper Deck 


Saturday March 28, 2015

7:00-7:55am - Continental Breakfast

7:55-8:00am - Opening Remarks

8:00-9:00am - Platform Session 2

8:00-8:15am - Clinical Risk Factors in ED Patients with Prescription Opioid Overdose
Lindsay Fox, MD
Icahn School of Medicine at Mount Sinai, New York, NY

8:15-8:30am - Is CYP2C19 Genotyping Useful Prior to New Drug Administration in an ED Population?
Howard S. Kim, MD 
Denver Health and Hospital Authority, Denver, CO

8:30-8:45am - Risk Factors Associated with Opioid Analgesic Prescribing in a Cross Section of Nineteen U.S. Emergency Departments
Josef G. Thundiyil, MD, FACMT
University of Central Florida College of Medicine, Orlando, FL

8:45-9:00am - Ambulatory Care and Emergency Department Prescribing Practices Do Not Account for Gender Differences in Opioid Analgesic-Related Deaths
Maryann Mazer-Amirshahi, MD, PharmD
MedStar Washington Hospital Center, Washington, DC

9:00-9:45am - Preventing Medication Exposures in Young Children: The Intersection of Medical Toxicology and Injury Prevention

budnitz.jpgDan Budnitz, MD, MPH, CAPT, USPHS
Director, Medication Safety Program, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention 


9:45-10:15am - Choosing Wisely in Medical Toxicology

Anne Michelle Ruha, MD, FACMT, Banner Good Samaritan Medical Center, Phoenix, AZ

10:15-10:30am - Break

10:30-11:30am - Poster Session 2: Authors with Posters

11:30am-1:00pm - Professional Development Session: (attend 2/3)   

A: Delivering an Effective Sound Bite
Heather Long, MD, Albany Medical Center, Albany, NY

B: Effective Practice Outreach Strategies
Moderator: Brenna M. Farmer, MD, FACMT, Weil Cornell Medical Center, NY, NY
Panelists: Ayrn D. O'Connor, MD, FACMT, Banner Good Samaritan Medical Center, Phoenix, AZ; Jerrold Leikin, MD, FACMT, NorthShore University HealthSystem, Evanston, IL; Stephen Munday,MD, MPH, FACMT, University of California-San Diego, San Diego, CA

C: Simulation for Medical Toxicology: More than Just a Manikin
Bryan S. Judge, MD, FACMT, Grand Rapids Medical Education Partners, Grand Rapids, MI; Matthew T. Emery, MD, Grand Rapids Medical Education Partners, Grand Rapids, MI

1:00-2:00pm - Special Luncheon Events

Fellows-In Training Luncheon: Professional Organizations and Your Medical Toxicology Career
Lewis S. Nelson, MD, FACMT, New York University School of Medicine, NY, NY; Adam C. Pomerleau, MD, Emory University, Atlanta, GA; Michelle Ruha, MD, FACMT, Banner Good Samaritan Medical Center, Phoenix, AZ ; Shawn M. Varney, MD, FACMT, University of Texas Health Sciences Center, San Antonio, TX

Students / Resident Luncheon (By Invitation)
Leslie R. Dye, MD, FACMT, President, ACMT; Louise W. Kao, MD, FACMT, Chair, 2015 Annual Scientific Meeting Planning Committee; Michele Burns, MD, FACMT, ACMT Board of Directors; Bryan S. Judge, MD, FACMT, 2015 Annual Scientific Meeting Planning Committee; Steve Munday, MD, MPH, FACMT, ACMT Board of Directors

CLBAquar.png Buschgardens.png Dalilogo.png header_trolley.png

Sunday, March 29, 2015

7:00-8:00am - Continental Breakfast

8:00-9:00am - ACMT Business Meeting

9:00-10:00am - Platform Session 3

9:00-9:15am - Cost-Effectiveness Analysis of Hemodialysis and Fomepizole vs. Fomepizole Alone in the Treatment of Toxic Alcohol Toxicity without Acidosis
Matthew Paul Davey, MD, Oregon Health & Science University, Portland, OR

9:15-9:30am - Effects of Medical Toxicology Specialty Care on Resource Utilization During Hospitalization of the Poisoned Patient
Andrew M. King, MD
Detroit Medical Center, Detroit, MI

9:30-9:45am The Rapid Growth of Drug-Overdose Deaths in Rural Counties from 1999-2012
Christopher Lim, MD, Toxikon Consortium, Chicago, IL

9:45-10:00am Clinical Course and Outcomes Associated with Different Treatment Modalities for Pediatric Bark Scorpion Envenomation
Anne-Michelle Ruha, MD, FACMT, Banner Good Samaritan Medical Center, Phoenix, AZ

10:00-11:00am - Poster Session 3:  Authors with Posters

11:00-11:45am - The Science Behind Package Insert Labeling

Reynolds.JPGKellie Schoolar Reynolds, PharmD

Division of Clinical Pharmacology IV (DCPIV), Food and Drug Administration


11:45am-12:15pm - Food Toxicology: What is the Evidence?

Josef G. Thundiyil, MD, FACMT, University of Central Florida College of Medicine, Orlando FL

12:15-12:45 - Pediatric Environmental Health: The Future for ACMT and Pediatric Toxicology

Moderator: Jennifer A. Lowry, MD, Children's Mercy Hospital, Kansas City, MO; Panelists: Carl R. Baum, MD, FACMT, Yale University School of Medicine, New Haven, CT; Paul M. Wax, MD, FACMT, University of Texas Southwestern, Dallas, TX



Day 1

Kenneth W. Kizer, MD, MPH, FACMT

Director, Institute for Population Health Improvement, UC Davis Health System, and Distinguished Professor, UC Davis School of Medicine (Department of Emergency Medicine) and the Betty Irene Moore School of Nursing

Dr. Kizer’s professional experience includes positions in academia and the public and private sectors. His previous positions have included: President, CEO and Chairman of Medsphere Systems Corporation, the nation’s leading commercial provider of open source healthcare information technology; founding President and CEO, National Quality Forum, a Washington, DC-based quality improvement and consensus standards setting organization; Under Secretary for Health, U.S. Department of Veterans Affairs and chief executive officer of the nation’s largest healthcare system; Director, California Department of Health Services; and Director, Emergency Medical Services Authority, State of California. He has served on the U.S. Preventive Services Task Force and as Chairman of the Board of The California Wellness Foundation, the nation’s largest philanthropy devoted to health promotion and disease prevention, as well as on the governing boards of managed care and health IT companies, several foundations and various professional associations and non-profit organizations. He also has worked in various capacities over the years with numerous foreign countries on health-related matters.

Dr. Kizer has been selected as one of the ‘100 Most Powerful People in Healthcare’ by Modern Healthcare magazine on several occasions, and his work has been featured in Time, BusinessWeek, Fortune, The Wall Street Journal, The New York Times and numerous other magazines, newspapers and national television shows.


Day 2

Dan Budnitz, MD, MPH, CAPT, USPHS

Director, Medication Safety Program, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention

Dr. Budnitz is the Director of CDC’s Medication Safety Program in the Division of Healthcare Quality Promotion. He has authored over 40 publications on medication safety monitoring, using national medication safety data to target safety measures, and applying lessons from injury prevention to drug safety. In 2008, he initiated a public-private collaboration to reduce medication ingestions and overdoses among young children, PROTECT (Preventing Overdoses and Treatment Errors in Children Taskforce).  Dr. Budnitz received a BA (Government) from Harvard University, and a combined MD/MPH (Epidemiology) from Emory University. After completing residency training in internal medicine at the Hospital of the University of Pennsylvania, he served as an Epidemic Intelligence Service (EIS) Officer with CDC’s Injury Center. Dr. Budnitz is currently a Captain in the US Public Health Service; and has practiced as a Board-Certified internist at the Atlanta VA Medical Center and the DeKalb-Grady Neighborhood Health Center.


 Day 3

Kellie Schoolar Reynolds, PharmD
Division of Clinical Pharmacology IV (DCPIV), Food and Drug Administration 

Dr. Reynolds is deputy director of the Division of Clinical Pharmacology IV in the Office of Clinical Pharmacology, Center for Drug Evaluation and Research (CDER), FDA.  Dr. Reynolds received her B.S. in Biochemistry from Virginia Tech and her Pharm.D. from Virginia Commonwealth University. She completed a fellowship in Clinical Pharmacokinetics and Drug Development at the University of North Carolina at Chapel Hill.  Her current work involves the application of clinical pharmacology to the development of antiviral, anti-infective, transplant and ophthalmology drugs.  Within these therapeutic areas, Dr. Reynolds’ professional and research interests include dose selection for individual patient sub-populations, factors affecting drug absorption, drug metabolism, drug interactions, and the communication of appropriate drug use information to health care providers and patients.  Related to communication, Dr. Reynolds has been involved with CDER activities aimed to improve the quality and clarity of drug product labeling.  In 2013 she co-lead the planning process for an FDA Advisory Committee meeting on the presentation of drug interaction information in drug product labeling.  She also delivered one of the FDA presentations at the meeting.  She is currently a member of several CDER working groups that are addressing drug product labeling issues.

In addition to her work at FDA, Dr. Reynolds is a member of the Board of Directors for the American Society of Clinical Pharmacology and Therapeutics (ASCPT) and is a member of their Strategic Planning Task Force and Mentoring Task Force.  She served as the chair of the Scientific Programming Committee in 2011.

Original  Research Abstracts Accepted September 1-November 17, 2014

The ACMT Annual Scientific Meeting welcomes all types of original research of interest to medical toxicologists and their patients. Please refer to the Abstract Submission Guidelines and Instructions (Click) for details. Questions? Email .


Clearwater Beach, Florida 
Tampa International Airport (TPA), 30 minutes
St. Petersburg / Clearwater Airport (PIE), 20 minutes

2015 ACMT Annual Scientific Meeting Planning Committee 

Louise W. Kao, MD, FACMT, Chair
Brenna M. Farmer, MD, FACMT, Co-Chair
Diane P. Calello, MD, FACMT
Bryan S. Judge, MD, FACMT
Erica L. Liebelt, MD, FACMT
Lewis S. Nelson, MD, FACMT
Ayrn D. O'Connor, MD, FACMT
Shan Yin, MD, MPH
Paul M. Wax, MD, FACMT
American College of Medical Toxicology
10645 N. Tatum Blvd., Suite 200-111
Phoenix, AZ 85028
T: 623 533 6340